Literature DB >> 10679800

High-level, stable expression of blood group antigens in a heterologous system.

K Yazdanbakhsh1, R Oyen, Q Yu, S Lee, M Antoniou, A Chaudhuri, M E Reid.   

Abstract

The detection and identification of blood group antibodies in patients is crucial for successful allogeneic blood transfusions. Current methods are highly subjective and rely on red blood cells (RBCs), which simultaneously express many blood group antigens, have a short shelf-life, and carry potential biohazard risks. To overcome these problems, we have used the approach of expressing individual blood group antigen-bearing proteins in a heterologous system. We report here the high-level surface expression of type I (Knops), type II (Kell), and type III/multi-pass (Duffy) membrane proteins that carry blood group antigens in mouse erythroleukaemic (MEL) cells using a vector containing the beta-globin locus control region. Importantly, the antigens expressed were detected specifically by a panel of patients' sera containing alloantibodies at sensitivities that are comparable to antigen-positive RBCs. Furthermore, in contrast to other mammalian expression systems, antigen expression was stable following freezing and thawing of the cell lines. Thus, this system has the potential both to replace the current use of RBCs by providing a one step method to detect and identify blood group antibodies and to allow the automation of antibody identification for the clinical laboratory. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10679800     DOI: 10.1002/(sici)1096-8652(200003)63:3<114::aid-ajh2>3.0.co;2-z

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  5 in total

Review 1.  DNA-based methods in the immunohematology reference laboratory.

Authors:  Marion E Reid; Gregory A Denomme
Journal:  Transfus Apher Sci       Date:  2011-01-22       Impact factor: 1.764

2.  Autoantibodies against complement receptor 1 (CD35) in SLE, liver cirrhosis and HIV-infected patients.

Authors:  S Sadallah; C Hess; M Trendelenburg; C Vedeler; M Lopez-Trascasa; J A Schifferli
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

3.  When recombinant proteins can replace rare red cells in immunohematology workups.

Authors:  Willy A Flegel; Kshitij Srivastava
Journal:  Transfusion       Date:  2021-05-31       Impact factor: 3.337

4.  Stabilization of Transfected Cells Expressing Low-Incidence Blood Group Antigens: Novel Methods Facilitating Their Use as Reagent-Cells.

Authors:  Cecilia González; Rosa Esteban; Carme Canals; Eduardo Muñiz-Díaz; Núria Nogués
Journal:  PLoS One       Date:  2016-09-07       Impact factor: 3.240

5.  Mice expressing RHAG and RHD human blood group genes.

Authors:  Dominique Goossens; Nelly da Silva; Sylvain Metral; Ulrich Cortes; Isabelle Callebaut; Julien Picot; Isabelle Mouro-Chanteloup; Jean-Pierre Cartron
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.